Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 28, 1998

View Archived Issues

CoCensys announces clinical results from phase II migraine trial

New dental agent reduces bleeding and plaque formation in patients with gingivitis

P&U amends NDA for once-monthly contraceptive injection

Ionotropic glutamate receptor ligands described by Lilly for CNS disorders

Anti-HIV-1 TBZ analogues synthesized and evaluated by European academic group

Copper conjugates inhibit influenza virus replication in vitro

Robustaflavone: synergistic anti-HBV activity observed in combination with 3TC and penciclovir

Symbollon begins evaluating fibrocystic breast disease therapeutic in the clinic

Melagatran in different vehicles compared in rat model of thrombosis

Latest preclinical data further supports antiasthmatic efficacy of betotastine besilate

Alpha2-adrenoceptor antagonists useful as adjuncts to L-DOPA in PD

Launch of Innotest Beta-Amyloid(1-42) test enables more reliable diagnosis of AD

NDA submitted for new inhaled influenza medication

CE Mark approval granted for AastromReplicell system components

Baxter, Inhale will seek partner to continue development of drug candidate

Genetronics targets prostate cancer as a new indication for electroporation therapy

Schering-Plough obtains promising results in phase I study of p53 gene therapy for NSCLC

Pivotal clinical trial results with i.v. Hectorol support NDA submission

Medeva seeks E.U. approval for third-generation hepatitis B vaccine

IDEA licenses drug delivery technology to Procter & Gamble

Purepac's generic diltiazem capsules tentatively approved by FDA

Complement inhibitor TP10 improves outcome in pig model of bypass surgery

Aquila's malaria vaccine immunogenic and well tolerated in phase I trial

Human trials of new liposomal ether lipid approved by FDA

RU-58841 shows potential as topical agent for alopecia and other skin disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...